Agnico Eagle Mines Limited (AEM)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,558	926.43	338.65	658.63	185.79	402.53
Short-Term Investments	11.58	7.31	10.2	9.9	5.29	3.94
Cash & Short-Term Investments	1,569	933.74	348.85	668.52	191.07	406.46
Cash Growth	68.65%	167.66%	-47.82%	249.87%	-52.99%	20.61%
Accounts Receivable	18.2	7.65	8.15	8.58	13.55	11.87
Other Receivables	137.36	181.98	176.76	135.32	89.12	88.62
Receivables	155.56	189.63	184.9	143.9	102.67	100.49
Inventory	1,502	1,511	1,419	1,209	878.94	630.47
Prepaid Expenses	155.06	124.57	151.74	110.65	90.68	72.5
Other Current Assets	106.18	46.64	86.72	47.91	39.02	37.26
Total Current Assets	3,488	2,805	2,191	2,180	1,302	1,247
Property, Plant & Equipment	22,007	21,466	21,222	18,459	7,676	7,325
Long-Term Investments	968.42	571.53	334.58	315.35	268.95	282.36
Goodwill	4,158	4,158	4,158	2,044	407.79	407.79
Other Intangible Assets	-	-	-	13.32	-	-
Long-Term Deferred Tax Assets	25.38	29.2	53.8	11.57	133.61	-
Other Long-Term Assets	1,038	944.8	715.74	467.05	389.82	330.75
Total Assets	31,693	29,987	28,685	23,495	10,216	9,615
Accounts Payable	893	296	317.89	259	189.07	167.13
Accrued Expenses	29.83	417.66	368.72	382.51	187.44	166.11
Current Portion of Long-Term Debt	50	90	100	100	225	-
Current Portion of Leases	37.24	40.31	46.39	36.47	32.99	20.85
Current Income Taxes Payable	612.23	372.2	81.22	4.19	47.21	102.69
Other Current Liabilities	95.91	295.81	133.81	164.26	80.11	58.92
Total Current Liabilities	1,718	1,512	1,048	946.42	761.81	515.7
Long-Term Debt	544.61	1,053	1,743	1,242	1,340	1,565
Long-Term Leases	101.83	98.92	115.15	114.88	98.45	99.42
Long-Term Unearned Revenue	-	34.89	24.05	13.96	-	-
Long-Term Deferred Tax Liabilities	5,200	5,162	4,973	3,982	1,223	1,036
Other Long-Term Liabilities	1,586	1,241	1,302	901.24	741.5	665.3
Total Liabilities	9,151	9,154	9,262	7,253	4,216	3,932
Common Stock	18,793	18,676	18,335	16,251	5,864	5,751
Additional Paid-In Capital	-	-	22.07	23.28	37.25	37.25
Retained Earnings	3,408	2,026	963.17	-201.58	-146.38	-366.41
Comprehensive Income & Other	342.23	131	102.8	168.42	245.39	260.89
Shareholders' Equity	22,542	20,833	19,423	16,241	6,000	5,683
Total Liabilities & Equity	31,693	29,987	28,685	23,495	10,216	9,615
Total Debt	733.69	1,282	2,005	1,493	1,697	1,686
Net Cash (Debt)	835.46	-348.45	-1,656	-824.89	-1,506	-1,279
Net Cash Per Share	1.66	-0.70	-3.38	-1.88	-6.15	-5.26
Filing Date Shares Outstanding	502.34	502.23	498.27	457.26	455.15	242.88
Total Common Shares Outstanding	502.34	501.73	497.3	456.47	245	242.88
Working Capital	1,770	1,293	1,143	1,234	540.58	731.49
Book Value Per Share	44.87	41.52	39.06	35.58	24.49	23.40
Tangible Book Value	18,385	16,675	15,265	14,184	5,592	5,275
Tangible Book Value Per Share	36.60	33.24	30.70	31.07	22.82	21.72
Machinery	-	13,292	12,458	10,491	6,942	6,529

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q